Airsupradupra

Quote

So....this "revolutionary" product is so good, Med D plans have decided to forgo formulary inclusion for 25'. AARP, SilverScript, Wellcare, Humana, etc have it all listed as a non-formulary product for 25'. Quite the "revolutionary" product. Just another product the org has over-priced based on nothing more than greed & arrogance. Remember Brilinta? Launching against generic clopidogrel and pricing it way too high. Those that don't learn from history are doomed to repeat it. Or as stated earlier, more like plain old greed & arrogance.
Oh and Biden was pushing for a $2 co-pay for albuterol for Med D patients. Have fun!
 


To above poster.... Airsupra will go the way of Bevespi. Funny how a certain someone ran the Bevespi failure and is now running the resp division. Must be really good at a certain somethin'. o_O
 


Sorta reminds me of a Sarah Palin comment a few years back . . . . . . You can put lipstick on a pig, but it's still a pig . . . . . . . and a VERY expensive pig that Airsupra is!
 






I wanted to wait several weeks to see if what was occurring with our largest & most consistent RXers was an anomaly or a trend. The reason why I am posting this now is because it is certainly a trend. We are seeing top writers drying up since the co-pay card change that took away the $15 override. With our largest commercial plans not covering Airsupra, providers are pulling back their usage. The worst part is, the patients who were on Airsupra and were leveraging the $15 override, now cannot so they are back on albuterol. This is obviously impacting Trx's. My question to all is: Is anyone else seeing this in their territories? I can't imagine we are the only ones.
 




anonymous said:
Nope. Just you. Get off of Social Media and go make some calls!!!
Click to expand...
This person either works for brand or has a very open access area or has little usage. For me, I am seeing it as well, especially with a couple of allergists. And I don't need three childish exclamation points to make that point known.
 


Glad someone posted this. Seeing similar drop in our territory with prescribers who said they used the override regularly. You have to wonder if "leaders" truly see the repercussions of actions taken? In our area commercial coverage is crappy. Those cards were our only solution to those patients getting Airsupra. Everyone in my district is looking... I will bet that we aren't the only district doing this.
 


anonymous said:
Glad someone posted this. Seeing similar drop in our territory with prescribers who said they used the override regularly. You have to wonder if "leaders" truly see the repercussions of actions taken? In our area commercial coverage is crappy. Those cards were our only solution to those patients getting Airsupra. Everyone in my district is looking... I will bet that we aren't the only district doing this.
Click to expand...
If you don’t like it, leave. With that attitude, we don’t want you here. Enough with the excuses.
 






Let's pile on....Heard from an allergist yesterday (was #1, now down to middle of pack) that the card issue definitely had an effect in prescribing. Doesn't take an MBA from Harvard (not that that carries the weight it once did) to realize that simple change would impact prescriptions. Bill Marr could have a field day with this brand team as part of his act. But hey, we now have wall clingy things to put everywhere. Who needs a PA bypass when we have clingy wall reminders?
 





Write your reply...
Top Bottom
Back
Quote